The role of mast cells (MCs) in contact hypersensitivity (CHS) remains controversial. This is due in part to the use of the MCdeficient Kit W/Wv mouse model, since Kit W/Wv mice congenitally lack other types of cells as a result of a point mutation in ckit. A recent study indicated that the intronic enhancer (IE) for Il4 gene transcription is essential for MCs but not in other cell types. The aim of this study is to re-evaluate the roles of MCs in CHS using mice in which MCs can be conditionally and specifically depleted. Transgenic Mas-TRECK mice in which MCs are depleted conditionally were newly generated using celltype specific gene regulation by IE. Using this mouse, CHS and FITC-induced cutaneous DC migration were analyzed. Chemotaxis assay and cytoplasmic Ca 2+ imaging were performed by co-culture of bone marrow-derived MCs (BMMCs) and bone marrow-derived dendritic cells (BMDCs). In Mas-TRECK mice, CHS was attenuated when MCs were depleted during the sensitization phase. In addition, both maturation and migration of skin DCs were abrogated by MC depletion. Consistently, BMMCs enhanced maturation and chemotaxis of BMDC in ICAM-1 and TNF-a dependent manners Furthermore, stimulated BMDCs increased intracellular Ca 2+ of MC upon direct interaction and up-regulated membrane-bound TNF-a on BMMCs. These results suggest that MCs enhance DC functions by interacting with DCs in the skin to establish the sensitization phase of CHS.
Introduction
Contact hypersensitivity (CHS) has been widely used to study cutaneous immune responses, since it is a prototype of delayed-type hypersensitivity mediated by antigen -specific T cells [1, 2, 3, 4 ]. An essential step in the sensitization phase for CHS is the migration of hapten-bearing cutaneous dendritic cells (DCs), such as epidermal Langerhans cells (LCs) and dermal DCs, into skin-draining lymph nodes (LNs). After completing their maturation, mature DCs present antigen to naive T cells in the LNs, thus establishing the sensitization phase. In the subsequent challenge phase, re-exposure to the cognate hapten results in the recruitment of antigen-specific T cells and other non-antigen-specific leukocytes.
The functions of cutaneous DCs are modulated by keratinocytederived proinflammatory cytokines [1, 5] . The role of the different skin DC subsets in CHS (inducers, regulators, or functional redundancy) is a matter of active debate [6] . In addition, dermal DCs, including Langerin (CD207) + dermal DCs, may also play an important role in CHS [7, 8] .
Mast cells (MCs) are a candidate DC modulator since they express and release a wide variety of intermediaries, such as histamine, tumor necrosis factor (TNF)-a and lipid mediators. It has been reported that activated human cord blood-derived MCs induce DC maturation in vitro [9] , that IgE-stimulated MC-derived histamine induces murine LC migration in vivo [10] , and that MCderived TNF-a promotes cutaneous murine DC migration in vivo in an IgE-independent manner [11] . On the other hand, prostaglandin (PG) D 2 produced by MCs in response to allergens [12] , inhibits LC migration [13] . Therefore, MCs might have bidirectional effects on DC activity in a context-dependent manner and the question of the mechanisms by which DCs are modulated by MCs is an important issue to pursue.
While MCs have been assumed to play an important role in CHS, their role is controversial. Previous studies have demonstrated that MC-deficient Kit W/Wv mice show attenuated CHS responses, meanwhile, other studies have shown that CHS was not impaired in Kit W/Wv mice [14] . Although some studies indicated that the discrepancy in W/Wv mice might be due to the difference in hapten dose, the detailed mechanism is still unclear. Kit W/Wv mice and Kit W-sh/KitW-sh mice have an inversion mutation in the Kit gene [15] , and therefore, these mice also lack melanocytes and hematopoietic stem cells, which are known to modulate immune responses [16, 17] . In addition, since MCs are congenitally absent, it is possible that compensatory mechanisms may exist that modulates immune system functions. Therefore, it is important to re-evaluate the roles of MCs using mice in which MCs can be conditionally and specifically depleted.
Recently, we have demonstrated that MCs and basophils use specific enhancer elements, intronic enhancer (IE) and a 39 4kb fragment that contains 39UTR and HS4 elements, to regulate Il4 gene expression, respectively [18] . Taking advantage of this system, we have generated mice that contain human diphtheria toxin receptor (DTR) under the control of IE. Therefore, mast cell-specific enhancer-mediated Toxin Receptor-mediated Conditional cell Knock out (TRECK) systems were designated as Mas-TRECK transgenic (Tg) mice. In these mice, both MCs and basophils are conditionally depleted by diphtheria toxin (DT) treatment. Since basophils recover much faster than MCs ( Fig  S1A, B) , there exist a period of specific MC depletion. Taking advantage of the system, we have herein demonstrated that activated DCs induce MC activation, which triggers the migration and maturation of DCs via cell-cell contact. This DC-MC interaction plays an essential role in the sensitization phase of CHS.
Results

Suppression of CHS responses in Mas-TRECK Tg mice
Mice expressing the human DTR under the control of IE element (for Mas-TRECK) and 39UTR element (for basophilspecific enhancer-mediated TRECK systems; Bas-TRECK) in the Il4 gene locus were generated by a transgenic strategy (Sawaguchi et al. Manuscript in submission). We initially demonstrated that skin MCs were completely depleted in Mas-TRECK Tg mice 5 and 12 days after an intraperitoneal injection of diphtheria toxin (DT) (See Fig. S1A in the Online Repository). Although DX5+ FceRIa+ basophils in the blood were eliminated 5 days after DT treatment in Mas-TRECK Tg mice, basophil numbers recovered in 12 days (Fig. S1B in the Online Repository).
To investigate the role of MCs in cutaneous acquired immune responses, we used DNFB-induced CHS as a model. CHS responses were similar between wild type (WT) and Mas-TRECK Tg mice in the absence of DT treatment (205 mm610.5 vs 212 mm612.3; average 6 SD). In addition, DT treatment itself did not affect the degree of CHS responses in WT mice. On the other hand, when both WT and Mas-TRECK Tg mice were treated with DT and assayed 12 days later, the CHS response in Mas-TRECK Tg mice was much less than that in WT mice (Fig. 1A) . The ear swelling of WT and Mas TRECK Tg mice was 48.2 (65.2, SD) mm and 51.3 (64.8, SD) m after 72 h, and 15 (67.29, SD) mm and 40.1 (66.68, SD) mm after 96 h respectively. Histology of the ears 48 h after the challenge showed considerable lymphocyte infiltration and edema in the dermis of sensitized WT mice; these changes were less apparent in Mas-TRECK Tg mice ( Fig. 1B, left panel) and the histological scores [19] in Mas-TRECK Tg mice were lower than those in WT mice ( Fig. 1B , right panel). On the other hand, the CHS response was not impaired in Kit W/Wv mice (See Fig. S2A in the Online Repository).
In addition, the CHS response in Bas-TRECK Tg mice, which lack only basophils upon treatment with DT, was similar to that of WT mice (See Fig. S2B in the Online Repository). The attenuated CHS response in Mas-TRECK Tg mice was confirmed using an additional hapten, oxazolone ( Fig. 1C ) and also at higher hapten doses (See Fig. S2C in the Online Repository).
To clarify the action phase of MCs in CHS, we used an adoptive transfer-induced CHS model. Recipients of LN cells from sensitized WT mice showed an enhanced CHS response, whereas the recipients of LN cells from sensitized Mas-TRECK Tg mice showed a markedly inhibited response ( Fig. 1D ). In addition, the recipients of CD90.2+ T cells from sensitized Mas-TRECK Tg mice showed inhibited responses compared to recipients of CD90.2+ T cells from sensitized WT mice (See Fig. S2D in the Online Repository). These data indicate that MCs play important roles in establishing CHS during the sensitization phase.
We further evaluated whether the attenuated CHS in Mas-TRECK Tg mice reflected the lack of MCs. WT or Mas-TRECK Tg mice were engrafted in the skin with or without BMMCs 5610 6 cells in 100 ml/dorsal skin 1 hour before oxazolone sensitization. The numbers of toluidine blue positive mast cells (per field) in the dermis are 40.2 (65.3, SD) in Mas TRECK Tg mice and 35.3 (67.2, SD) in B6 wild type mice after one hour injection of BMMC (n = 3) (See Fig. S2E in the Online Repository). On the other hand, the number of MCs in the uninjected sites was 10.5 (63.2, SD) in B6 wild type mice. Five days after sensitization, the skin-draining LN cells of sensitized mice were adoptively transferred intravenously into naive WT recipients and challenged with oxazolone on the ears. The CHS response of recipients of LN cells from sensitized WT mice was not changed by the pre-engraftment of BMMCs into the skin (Fig. 1E ). On the other hand, the attenuated CHS response of recipients of Mas-TRECK Tg LN cells was fully restored by the pre-engraftment of BMMCs into the skin.
Next we counted the cells infiltrating the skin of WT and Mas-TRECK Tg mice 12 h after challenge with DNFB. The numbers of CD45+ CD3+ CD4+ T cells, CD45+ CD3+ CD8+ T cells, and CD45+ Gr-1high neutrophils after both sensitization and challenge, and that of neutrophils after only challenge were increased in WT mice. But such increment was attenuated in Mas-TRECK Tg mice (See Fig. S3A in the Online Repository). Consistent with this result, the mRNA levels of IFN-c, IL-17 and IL-1b in the skin 12 h after challenge were significantly decreased in Mas-TRECK Tg mice compared to WT mice (See Fig. S3B in the Online Repository).
We further analyzed the composition of LN cells after sensitization. Five days after sensitization, the skin-draining LN cells of WT and Mas-TRECK Tg mice were collected. The numbers of CD44+ CD62L+ central memory T cells and CD44+ CD62L-effector memory T cells among CD4+ and CD8+ T cell subsets were less in Mas-TRECK Tg mice than in WT mice (See Fig. S4A in the Online Repository). In contrast, the numbers within each subset in the LN without sensitization were comparable between WT and Mas-TRECK Tg mice (See Fig.  S4A in the Online Repository).
To evaluate of T cell differentiation after sensitization, the skindraining LN cells from control or DNFB-sensitized WT and Mas-TRECK Tg mice were challenged in the presence or absence of DNBS in vitro. The incorporation of 3 H-thymidine and the levels of IFN-c and IL-17 in the culture supernatant in the presence of DNBS were markedly decreased in LN cells from Mas-TRECK Tg mice as compared with those from WT mice (See Fig. S4B -D in the Online Repository). The levels of IL-4 in the culture supernatants were below the limit of detection of ELISA (,0.3 pg/mL).
Attenuated DC migration and maturation in the skindraining LNs of Mas-TRECK Tg mice
An essential step in the sensitization phase for CHS is the migration of hapten-bearing cutaneous dendritic cells (DCs), such as epidermal Langerhans cells (LCs) and dermal DCs, into skindraining lymph nodes (LNs). Accordingly, to dissect the site of action of MCs in the sensitization phase, we initially focused on cutaneous DCs that have an opportunity to interact with MCs present in the dermis.
Using a FITC-induced cutaneous DC migration model, we found that the numbers of both FITC + CD11c + MHC class II + CD207 + DCs and FITC + CD11c + MHC class II + CD207 2 DCs in the draining LNs 24 h and 72 h after FITC application were significantly attenuated in Mas-TRECK Tg mice compared to WT mice ( Fig. 2A, B ). In addition, the numbers of total CD4 + and CD8 + T cells, and CD44 + CD62L + central memory and CD44 + CD62L 2 effector memory T cells in the draining LNs of Mas-TRECK Tg mice were less than those of WT mice (Fig. 2C) . We next analyzed the expression levels of costimulatory molecules by skin organ culture. We incubated the skin and analyzed the expression levels on crawl-out DCs in the culture medium. The expression levels of CD40, CD80, and CD86 both on CD11c + MHC class II + EpCAM + LCs and CD11c + MHC class II + EpCAM 2 dermal DCs in Mas-TRECK Tg mice were lower than those of WT mice ( Fig. 2D , E, and see Consistently, LCs and dermal DCs from Kit+/+ mice were similar to those from Kit W/Wv mice (See Fig. S5B in the Online Repository).
We further evaluated the effect of MCs on the antigen presenting capacity of DCs. We sorted 5610 5 T cells by auto MACS from the draining LNs of CD90.2 + WT mice five days after 25 ml of 2% oxazolone application. These CD90.2 + T cells were incubated for 72 h with or without CD11c + DCs (1610 5 cells) prepared from the draining LNs of WT or Mas-TRECK Tg mice one day after oxazolone application. T cell proliferation was enhanced by the addition of antigen-acquired DCs sorted from the draining LN of sensitized mice, and the extent of augmentation by DCs from WT mice was much higher than that of DCs from Mas-TRECK Tg mice ( Fig. 2F ).
Enhancement of BMDC maturation and chemotaxis by BMMC requires cell-cell contact in vitro
Impairment of DC functions as a result of MC deficiency suggests that MCs stimulate cutaneous DCs. To address this hypothesis, we prepared BMDCs [20] and incubated them with or without BMMCs. Co-cultivation of BMDCs with BMMCs for 24 h significantly increased the expression levels of CD40, CD80, CD86 and CCR7 on BMDCs (Fig. 3A) . In addition the chemotaxis of BMDCs to CCL21 was significantly enhanced, when BMMCs were added to the upper chamber with BMDCs ( Fig. 3B ).
Furthermore addition of BMMCs to the upper chamber of transwells did not induce further up-regulation of CD40, CD80, CD86 and CCR7 levels on BMDCs incubated in the lower chamber ( Fig. 3C) , which suggests that BMMCs require direct cell-cell interaction to stimulate BMDCs.
Stimulation of BMMCs by activated BMDCs
We then examined in vitro whether DCs directly contacted MCs. We incubated BMMCs and BMDCs, and found that c-kit + BMMCs contacted MHC class II + BMDCs (Fig. 4A) . A number of FceRIa + CD11c 2 MCs co-localized with CD11c + DCs in ear dermis 24 h after sensitization with DNFB ( Fig. 4B) . Consistent with this, the number of MCs co-located with DCs after sensitization was higher than that in the steady state (in other words, in non-inflammatory conditions) (460.81 vs 0.360.58; average 6 SD).
At present, several stimuli in addition to IgE are known to trigger calcium influx and activate MCs [21] . Therefore, we studied the effect of BMDCs on BMMCs using Ca 2+ imaging. We incubated tetramethylrhodamine ethyl ester (TMRE)-labeled BMDCs and Fluo-8-labeled BMMCs together. When an intracellular Ca 2+ concentration of Fluo-8 (green) -labeled BMMCs is upregulated, fluorescence intensity of green becomes increased. Unstimulated CD11c + MHC class II int+ BMDCs did not increase BMMC intracellular Ca 2+ concentrations (Fig. 4C , See Video S1 in the Online Repository). On the other hand, stimulated CD11c + MHC class II high+ BMDCs induced prominent Ca 2+ increase in BMMCs ( Fig. 4D and See Video S2 in the Online Repository). This rapid rise occurred five to ten times in 1000 seconds, and each spike lasted about 10-20 sec (Fig. 4E) . Stimulated BMDCs significantly upregulated the ratio of BMMCs with increased Ca 2+ concentration compared to non-stimulated BMDCs (Fig. 4F) . These results suggest that stimulated DCs activate MCs via direct cell-cell contact.
Stimulation of DCs by MCs is dependent on ICAM-1-LFA-1 interaction and on MC membrane-bound TNF-a
We then sought to identify how MCs promote DC maturation. It has been reported that ICAM-1 on the surface of MCs directly interacts with leukocyte function-associated antigen 1 (LFA-1) on T cells, and that stimuli such as CD40L, LPS, and TNF-a, upregulate the expression of ICAM-1 on DCs [22] . In fact, the expression of ICAM-1 on BMDCs was up-regulated upon stimulation of BMDCs by LPS and CCL21 (Fig. 5A) . Therefore, we hypothesized that MCs and DCs interact in an ICAM-1-and LFA-1-dependent manner. Addition of neutralizing anti-ICAM-1 antibody to a culture of BMDCs completely inhibited upregulation of CD40, CD80 and CD86 expression on BMDCs upon addition of BMMC (Fig. 5B, S6A) .
We then analyzed intracellular signaling using the protein kinase A inhibitor, H89, and the phosphoinositide 3 kinase inhibitor, wortmannin. Although H89 did not inhibit the BMMCinduced upregulation of co-stimulatory molecules on BMDCs, wortmannin inhibited DC maturation (Fig. 5C, S6B) . These results suggest that binding of ICAM-1 to LFA-1 activates DCs through a PI3-kinase pathway.
Lastly we tried to identify how DCs induce MC activation. TNF-a is first produced as a 26 kDa transmembrane molecule (membrane-bound TNF-a), which is cleaved by the metalloproteinase-disintegrin TNF-a converting enzyme TACE [23] to generate a soluble 17 kDa TNF-a. Studies have shown that membrane-bound TNF-a is also biologically active [24] . We first observed that anti-TNF-a antibody completely blocked DC maturation induced by BMMCs (Fig. 5B) . Consistently, BMMC from TNF-a KO mice did not promote BMDC maturation (Fig.  S6C) . But the soluble form of TNF-a in the supernatant of cocultures of BMMCs and TNF-a KO-derived BMDCs was below the detection limit irrespective of BMDC stimulation (,8 pg/ml, each). On the other hand, the level of membrane-bound TNF-a on BMMCs was increased by the addition of BMDCs and even further enhanced when stimulated BMDCs were added (Fig. 5D) . These results suggest that MCs express membrane-bound TNF-a upon direct interaction with activated DCs through ICAM-1 on DCs and that membrane-bound TNF-a induces expression of costimulatory molecules on DCs.
Discussion
In this study, we used Mas-TRECK Tg mice in which MCs can be eliminated specifically and conditionally, and demonstrated that CHS was significantly attenuated in accord with impaired memory T cell induction in skin-draining LNs after sensitization. MC depletion also impaired hapten-induced cutaneous DC migration concordant with levels of co-stimulatory molecule expression. In addition, BMMCs promoted BMDC maturation and chemotactic activity by direct interaction via ICAM-1 and membrane-bound TNF-a. In fact, a certain number of DCs were found colocalized with MCs in the DNFB-sensitized dermis. These findings suggest that MCs may promote migration and maturation of dermal DCs and epidermal LCs to establish the sensitization phase of CHS.
It was previously reported that FITC-induced cutaneous DC migration was attenuated in Kit W-sh/KitW-sh mice at 24 h, but not at 48 or 72 h after FITC application, and that the sensitization phase of CHS was not attenuated in Kit W-sh/KitW-sh mice [11] . The above findings were inconsistent with our findings in the way that cutaneous DC migration was attenuated even at 72 h after FITC application and that sensitization phase was impaired in Mas-TRECK Tg mice. On the other hand, it has also been shown that MCs are capable of influence both the sensitization phase and the elicitation phase in other models of CHS [25] . Therefore, it still remains unknown how the discrepancy occurred. The difference between our model and Kit W/Wv and Kit W-sh/KitW-sh mice is the existence of melanocytes and hematopoietic stem cells. Recently, melanocytes were shown to express toll like receptors, to modulate immune responses and to produce IL-1a and IL-1b [16, 17] . In addition, because of congenital absence of MCs in Kit W/Wv and Kit W-sh/KitW-sh mice, compensatory mechanism may exist, such as repopulation of basophils. In fact, the numbers of basophils have been counted in these mice; the number of basophils in in Kit W/Wv mice are lower than that in WT mice, and that in Kit W-sh/KitW-sh mice are higher than that in WT mice [26] . These results indicate that the compensatory mechanisms may affect the result of CHS responses and that Kit W/Wv and Kit W-sh/KitW-sh mice may not necessarily be representative to evaluate the roles of pure MCs. In this study, we have demonstrated that the attenuated CHS response in Mas TRECK Tg mice was fully restored by the preengraftment of BMMCs into the skin just before sensitization with hapten. It is intriguing to evaluate this recovery by means of reconstitution with native skin MCs, since freshly generated BMMC and native skin MCs can differ in aspects of phenotype and function. We can't perform long term engraftment of BMMC in this model because we have found that repeated DT treatment (more than 5 days of daily injection) leads to weak viability of the Mas TRECK Tg mice.
We showed that co-culture of DCs with MCs did not promote soluble TNF-a secretion from MCs but up-regulated membranebound TNF-a on MCs. Since TNF-a expressed on MCs in this context is membrane-bound, MCs are required to co-localize with DCs in vivo to elicit its effect. Since neutralizing anti-TNF-a Ab abrogated the BMMC-induced DC maturation, membrane-bound TNF-a on MCs might be the major modulator of DC maturation. Herein we have focused on the roles of MCs in the sensitization phase, but we also noted that MC depletion in the elicitation phase attenuated the CHS response. Since DCs are thought to present antigen to memory T cells to initiate the challenge phase of CHS, the interaction of MCs and DCs might be essential for its establishment, which is a question that will be pursued in a future study.
The direct interaction between DCs and MCs was essential not only for DC stimulation, but also for MC activation. Previous reports have demonstrated that MCs contact extracellular matrix components to provide a co-stimulatory signal for histamine and cytokine production via integrins [27] . MCs are known to degranulate upon binding of ICAM-1 on MCs and LFA-1 on activated T cells [28] . In agreement with this, our study demonstrates that the interaction of MCs with DCs is dependent on cell-cell contact via ICAM-1 and LFA-1. In addition, an influx of calcium in MCs is induced by activated DCs that express high levels of ICAM-1, but not by immature DCs. Therefore, in sensitized skin, activated DCs bind to MCs and promote activation and up-regulating membrane-bound TNF-a on MCs. Activated MCs further promote additional activation of hapten-bearing cutaneous DCs causing them to migrate into skin-draining LNs. These findings indicate that MCs play an essential role in 
Materials and Methods
Mice
Mice expressing the human DTR under the control of IE element (for Mas-TRECK) and 39UTR element (for Bas-TRECK) in the Il4 locus were generated by a transgenic strategy. The basic pIL-4 construct was made by insertion of the 59enhancer (59E) (2863 to 25448; start codon is defined as sequence number 0) [29] and the IL-4 promoter from position 264 to 2827. Human DTR fragment was isolated from human DTR/pMS7 vector that was provided by Dr. M. Tanaka (RCAI, RIKEN, Yokohama, Japan) and inserted into the basic pIL-4 construct. IE (+311 to +3534) and 39UTR (+6231 to +10678) fragments were isolated from a mouse YAC clone (catalog no. 95022; Research Genetics, Huntsville, AL) and inserted into the basic pIL-4 and human DTR construct respectively. Each transgenic (Tg) line was generated on a C57BL/6 background. C57BL/6 (B6, WT) mice were purchased from Japan SLC (Shizuoka, Japan). TNF-a KO mice on the C57BL/6 background were generated [30] . WBB6F1-Kit+/+ and -Kit W/Wv mice were obtained from The Jackson Laboratory. For DT treatment, mice were injected intraperitoneally with 250 ng of DT in 250 ml of PBS per mouse for five consecutive days. Eight to ten week-old female mice were used for all the experiments and bred in specific pathogen-free facilities at Kyoto University. All experimental procedures were approved by the institutional animal care and use committee of Kyoto University Graduate School of Medicine (MedKyo11100).
Reagents, antibodies and intracellular staining
We purchased dinitrofluorobenzene (DNFB) from Nacalai Tesque (Kyoto, Japan), 2,4-dinitrobenzene sulfonic acid (DNBS) from Alfa Aesar (Ward Hill, MA). FITC-, PE-, PE-Cy5-, PE-Cy7-, APC-, APC-7-, and Pacific Blue-conjugated 145-2C11 (anti-CD3), GK1.5 (anti-CD4), 53-6.7 (anti-CD8), N418 (anti-CD11c), 1C10 (anti-CD40), 30-F11 (anti-CD45), 16-10A1 (anti-CD80), GL1 (anti-CD86), M5/114.15.2 (anti-MHC class II), MEL-14 (anti-CD62L), IM7 (anti-CD44), eBioKAT-1 (anti-intercellular adhesion molecule 1 (ICAM-1)), eBioL31 (anti-CD207), RB6-8C5 (anti-Gr-1), 4B12 (anti-CCR7)(eBioscience, San Diego, CA), and G8.8 (anti-EpCAM) (BioLegend, San Diego, CA) were purchased.
For Langerin (CD207) staining, cells were fixed and permeabilized with cytofix/cytoperm solution (BD Biosciences, San Jose, CA), and stained with biotin-conjugated anti-Langerin Ab. Cells were analyzed with FACSCantoII (BD, Franklin Lakes, NJ).
Histology and immunohistochemistry
Hematoxylin-eosin and toluidine blue staining [31] , and the histological scoring were evaluated as reported [19] . In brief, samples were scored for the severity and character of the inflammatory response using a subjective grading scale. Responses were graded as follows: 0, no response; 1, minimal response; 2, mild response; 3, moderate response; and 4, marked response. The slides were blinded, randomized, and reread to determine the histology score. All studies were read by the same pathologist using the same subjective grading scale. The total histology score was calculated as the sum of scores, including inflammation, neutrophils, mononuclear cells, edema, and epithelial hyperplasia.
For immunohistochemistry, cryosections were fixed in acetone, incubated with hamster anti-mouse CD11c (eBioscience) followed by goat anti-hamster AlexaFluor488 (Invitrogen, Carlsbad, CA), and were subsequently incubated with PE-conjugated anti-mouse FceRIa (eBioscience). Fluorescence images with DAPI staining were obtained using a BIOREVO BZ-9000 system (Keyence, Osaka, Japan).
Quantitative PCR analysis
Total RNAs were isolated with Trizol (Invitrogen) from ear skin. cDNA was reverse transcribed using a PrimeScript RT reagent kit (Takara Bio, Otsu, Japan). Quantitative RT-PCR with a Light Cycler real time PCR apparatus was performed (Roche Diagnostics, Foster City, CA) using SYBR Green I (Takara Bio). Primers for Ifng, Il17, and Il1b were obtained from Hokkaido System Science (Sapporo, Japan) and the primer sequences were Ifng, 59-ATG AAC GCT ACA CAC TGC ATC -39 (Forward) and 59-CCA TCC TTT TGC CAG TTC CTC -39 (reverse); Il17, 59-TTT AAC TCC CTT GGC GCA AAA -39 (forward), 59-CTT TCC CTC CGC ATT GAC AC -39 (reverse); and Il1b, 59-GCA ACT GTT CCT GAA CTC AAC T -39 (forward), 59-ATC TTT TGG GGT CCG TCA ACT -39 (reverse). For each sample, triplicate test reactions and a control reaction lacking reverse transcriptase were analyzed for expression of the genes and results were normalized to those of the 'housekeeping' glyceraldehyde-3phosphate dehydrogenase (Gapdh) levels.
Lymphocyte proliferation assay and cytokine production
For DNBS-dependent proliferation, single-cell suspensions from skin-draining LNs of mice 5 days after sensitization with DNFB. One million LN cells were cultured with or without 100 mg/ml of DNBS for 72 h, pulsed with 0.5 mCi 3H-thymidine for the last 24 h, and subjected to liquid scintillation counting.
For measurement of cytokine production, the culture supernatants were collected 72 h after incubation and were measured by ELISA (BD Biosciences and R&D systems, Minneapolis, MN) according to the manufacture's protocol.
CHS protocol
Mice were sensitized with 50 ml of 0.5% (w/v) DNFB in acetone/olive oil (4/1) or 2% oxazolone (Wako Pure Chemical Industries, Ltd, Osaka, Japan) in ethanol on abdominal skin. On day 5, the ears were challenged by application of 20 ml of 0.3% DNFB or 1% oxazolone.
For adoptive transfer, LN cells were prepared from the inguinal and axillary LNs of one mouse sensitized with DNFB 5 days previously, and transferred intravenously into a mouse. The ears of these animals were challenged with 20 ml of 0.3% DNFB 1 h later, and the ear thickness change was measured. For adoptive transfer of T cells, T cells purified with CD90.2 + microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) were prepared from the inguinal and axillary LNs of a mouse sensitized with 2% oxazolone 5 days previously, and transferred intravenously into a mouse. The ears of these animals were challenged with 20 ml of 1% oxazolone 1 h later, and the ear thickness change was measured.
Generation of BMDC and BMMC
Complete RPMI (cRPMI), RPMI 1640 medium (Sigma, St. Louis, MO) containing 10% fetal calf serum (Invitrogen), was used as culture medium. For BMDC induction, 5610 6 BM cells were cultured supplemented with 10 ng/ml recombinant murine GM-CSF (PeproTech, Rocky Hill, NJ) for five days [20] (.90% expressed CD11c).
For BMMC induction, 1610 6 BM cells were cultured supplemented with 5 ng/ml recombinant murine SCF and IL-3 (PeproTech) for more than three weeks (.98% expressed c-kit and FceRIa).
For organ culture assay, the skin from mouse ears was split along with cartilage, and the dorsal ear skin without cartilage was floated in a dermal side-down manner in 24-well tissue culture plates. Twentyfour hours later, the cells in the wells were collected for analysis.
Chemotaxis assay and FITC-induced cutaneous DC migration
Cells were tested for transmigration to CCL21 (R&D Systems) or medium in the lower chamber across uncoated 5-mm transwell filters (Corning Costar Corp., Corning, NY) for 6 h and were enumerated by flow cytometry.
For FITC-induced cutaneous DC migration, mice were painted on the shaved abdomen with 100 ml of 2% FITC (Sigma) dissolved in a 1:1 (v/v) acetone/dibutyl phthalate (Sigma) mixture, and the number of migrated cutaneous DCs into draining LNs was enumerated by flow cytometry.
Co-culture of BMDCs and BMMCs
BMDCs and starved BMMCs were co-cultured at a density of 2610 5 DCs in 200 ml per well in a 96-well microplate at a DC:MC ratio of 2:1 and the co-culture was performed for 24 h. Separation of BMDCs and BMMCs was performed by using transwell culture plates with a 3-mm pore size (Costar, Corning). To observe cell-cell contact in vitro, BMDCs and BMMCs were cocultured on poly-L-lysine coated glass coverslips (ASAHI GLASS Co., LTD, Tokyo, Japan) for 24 h and stained with FITCconjugated anti-c-Kit and PE-conjugated anti-MHC class II.
For inhibition assays, BMDCs and starved BMMCs were cocultured with or without 5 mg/ml of isotype control Ab (Rat IgG2b, eBioscience), 20 mg/ml of anti-ICAM-1 Ab (YN1/1.7.4, eBioscience) or 5 mg/ml of anti-TNF-a Ab (MP6-XT22, eBioscience) for 24 h. Starved BMMCs were pretreated with or without wortmannin (100 nM; Sigma) or H89 (10 mM; Sigma) for 1 h and then co-cultured with BMDCs for 24 h.
For detection of membrane-bound TNF-a, starved BMMCs were cultured for 24 h with or without non-stimulated or stimulated BMDCs with 100 ng/ml of LPS (Sigma) and 50 ng/ ml of CCL21 (R&D systems) for 1 h.
Cytoplasmic Ca 2+ imaging
BMMCs were incubated with 5 mM Quest Fluo-8 AM (ABD Bioquest, CA, USA), and BMDCs were stimulated with 100 ng/ ml of LPS and 50 ng/ml of CCL21 for 1 h and stained with 2.5 nM tetramethylrhodamine ethyl ester (TMRE) (Invitrogen). The Fluo-8 image and the transmission image were recorded every 10 sec using a back-thinned electron multiplier CCD camera (ImagEM, Hamamatsu Photonics, Japan) and microscope (Eclipse Ti, Nikon, Japan). The fluorescence intensity was expressed as a ratio to the initial value after subtracting background fluorescence.
Statistical analysis
Unless otherwise indicated, data are presented as the means 6 standard deviation (SD) and are a representative of three independent experiments. P-values were calculated with the twotailed Student's t-test or one-way ANOVA followed by the Dunnett multiple comparison test. P values less than 0.05 are considered to be significantly different between MasTRECK and corresponding WT mice and are shown as * in the figures. Video S1 Quest Fluo-8 AM-stained BMMCs and TMREstained BMMCs were mixed on glass coverslips and recorded every 10 sec at ,306C using a back-thinned electron multiplier CCD camera.
Supporting Information
(MOV)
Video S2 Quest Fluo-8 AM-stained BMMCs and TMREstained stimulated BMMCs were mixed on glass coverslips and recorded every 10 sec at ,306C using a backthinned electron multiplier CCD camera. (MOV)
